Quantum company
NVision Imaging Technologies
Quantum hyperpolarization for metabolic MRI, expanding into photonic quantum computing with molecular qubits.
Technology
NVision, headquartered in Ulm, Germany, develops quantum metabolic polarizers that make metabolic MRI usable in cancer care. In May 2026 it announced a $55 million Series B anchored by Abbott and an expansion into quantum computing based on photonic integrated quantum circuits with single photon emitting molecules as qubits.
Companies
No investor from our directory is on this company’s cap table yet.